menu search

Why shares of schrödinger are falling thursday

Second-quarter revenue was down 9% year over year. Schrödinger increased revenue guidance for software revenue but decreased it for drug discovery....

August 3, 2023, 8:17 pm

2 bull signals flashing for synchrony financial stock

Synchrony Financial (NYSE:SYF) has been pulling back from its mid-July peak and is currently on track f...

August 3, 2023, 2:22 pm

Schrodinger, inc. (sdgr) reports q2 loss, misses revenue estimates

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus E...

August 2, 2023, 8:58 pm

chromadex to report second quarter 2023 financial results on wednesday, august 9, 2023

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #chromaDex--chrom...

August 2, 2023, 8:02 am

Optinose: the worst has been avoided (rating upgrade)

On August 10, OptiNose, one of the leaders in the global chronic rhinosinusitis market, will publish it...

August 1, 2023, 6:58 pm

Aviv clinics highlights new literature review sharing the efficacy of hyperbaric oxygen therapy for traumatic brain injury patients

Literature review finds that hyperbaric oxygen therapy should be recommended in chronic traumatic brain...

August 1, 2023, 5:24 pm

High-sensitivity troponin assays may stratify risk in chronic cad

An exploratory analysis suggests an elevated troponin level may identify patients who would benefit from revascularization. Read Full Story at source ...

August 1, 2023, 4:03 pm

Archrock inc. (aroc) surpasses q2 earnings and revenue estimates

Archrock Inc. (AROC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus E...

July 31, 2023, 8:54 pm

Waters (wat) to report q2 earnings: what's in the offing?

Waters' (WAT) second-quarter 2023 results are likely to reflect strength in liquid chromatography instr...

July 28, 2023, 2:00 pm

Okyo pharma inks collaboration with tufts medical center

OKYO Pharma Ltd (NASDAQ:OKYO) has revealed a new partnership with Tufts Medical Center to conduct an open-label clinical trial to assess the efficacy ...

July 28, 2023, 8:11 am

Semler to report second quarter 2023 financial results and host conference call on august 10, 2023

SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovati...

July 28, 2023, 8:03 am

Changing meta's algorithms did not help us political polarization, study finds

Study of Facebook and Instagram data from 2020 election shows chronological lists had no measurable imp...

July 27, 2023, 5:00 pm

Google ordered to pay $339m in damages following chromecast ruling

A federal jury in Waco, Texas, has ruled that Google, a subsidiary of Alphabet Inc (NASDAQ:GOOG), infringed on the patent rights of software developer...

July 25, 2023, 3:09 am

Microsoft's bing chat comes to chrome and safari in tests for ‘select users'

Microsoft's AI chatbot, Bing Chat, is coming to non-Microsoft browsers the company today confirmed following various reports of the AI chatbot being s...

July 24, 2023, 4:31 pm

Big pharma bets on china's aging population

Certain industries have reduced their presence and or reliance on the Chinese market in 2023, but Big Pharma isn't one of them, according to reporting...

July 24, 2023, 4:09 pm

Synchrony financial (syf) hikes quarterly dividend payout by 9%

Synchrony Financial's (SYF) recent dividend hike of 9% reflects its intention to enhance shareholders' ...

July 24, 2023, 1:50 pm

Biosimilar contract manufacturing market size to hit usd 26.1 billion by 2032 at 18.90% cagr – report by market research future (mrfr)

Biosimilar Contract Manufacturing Market Trends and Insights By Product (Recombinant Non-glycosylated Proteins and Recombinant Glycosylated Proteins),...

July 24, 2023, 11:34 am

Schroders notes 3 potential catalysts for asian equities, cheap valuations for a/ h shrs

Spot USD/CNY Dives 241 bps at Close, Ebbing Below 7.2 … Read Full Story at source (may require registration) The post S...

July 24, 2023, 11:14 am

Grupo financiero banorte, s.a.b. de c.v. (gboof) q2 2023 earnings call transcript

Grupo Financiero Banorte, S.A.B. de C.V. (OTCQX:GBOOF) Q2 2023 Earnings Conference Call July 21, 2023 11:00 AM ET Company Participants Tomás Lozano -...

July 21, 2023, 9:49 pm

Why shares of argenx jumped this week

Argenx has only two approved therapies, Vyvgart and Vyvgart Hytrulo. Vyvgart Hytrulo fared well in a trial to treat adults with ...

July 21, 2023, 1:17 pm


Search within

Pages Search Results: